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Background/Objectives: New tools to accurately identify poten-
tially preventable 30-day readmissions are needed. The HOSPITAL
score has been internationally validated for medical inpatients, but
its performance in select conditions targeted by the Hospital Re-
admission Reduction Program (HRRP) is unknown.
Design: Retrospective cohort study.
Setting: Six geographically diverse medical centers.
Participants/Exposures: All consecutive adult medical patients
discharged alive in 2011 with 1 of the 4 medical conditions targeted
by the HRRP (acute myocardial infarction, chronic obstructive
pulmonary disease, pneumonia, and heart failure) were included.
Potentially preventable 30-day readmissions were identified using
the SQLape algorithm. The HOSPITAL score was calculated for all
patients.
Measurements: A multivariable logistic regression model ac-
counting for hospital effects was used to evaluate the accuracy
(Brier score), discrimination (c-statistic), and calibration (Pearson
goodness-of-fit) of the HOSPITAL score for each 4 medical con-
ditions.
Results: Among the 9181 patients included, the overall 30-day po-
tentially preventable readmission rate was 13.6%. Across all 4 di-
agnoses, the HOSPITAL score had very good accuracy (Brier score
of 0.11), good discrimination (c-statistic of 0.68), and excellent cal-
ibration (Hosmer-Lemeshow goodness-of-fit test, P=0.77). Within
each diagnosis, performance was similar. In sensitivity analyses,
performance was similar for all readmissions (not just potentially
preventable) and when restricted to patients age 65 and above.
Conclusions: The HOSPITAL score identifies a high-risk cohort for
potentially preventable readmissions in a variety of practice set-
tings, including conditions targeted by the HRRP. It may be a
valuable tool when included in interventions to reduce readmissions
within or across these conditions.
Key Words: patient readmission, score, risk factors, transition of
care
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Under the Affordable Care Act, the Center of Medicareand Medicaid Services (CMS) calculates average risk-
adjusted 30-day hospital readmission rates for selected
conditions and penalizes hospitals with above-average
rates.1,2 The amount of the penalty and the number of con-
ditions targeted has expanded as the introduction of the
Hospital Readmissions Reduction Program (HRRP) in 2012,
affecting 78% of hospitals nationally in 2015 with projected
total penalties of $428 million.3
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Given this expansion, hospitals are seeking to reduce
readmissions for penalized conditions. Best practices for
doing so include identifying a high-risk cohort, compre-
hensively assessing potentially modifiable readmission risks,
and targeting these risks.4–7 Progress in this regard has been
hindered by lack of a validated tool that could identify po-
tentially preventable readmissions, particularly for con-
ditions targeted by the HRRP. The HOSPITAL score was
recently shown to identify patients at risk for potentially
preventable readmissions in a cohort of discharged patients
across 9 hospitals in 4 different countries.8,9 However, its
performance specifically on selected conditions targeted by
the HRRP is unknown. Establishing its performance for each
of these conditions is important as hospitals may not face
penalties for each condition, and often wish to institute
disease-specific interventions to reduce readmissions.10 If the
HOSPITAL score has reasonable performance for these
conditions, its international validation and ability to exclude
nonpreventable readmissions may hold promise for hospitals
and clinicians intervening to reduce readmissions. We sought
to validate the HOSPITAL score for predicting potentially
preventable readmissions within each of the medical con-
ditions targeted by the HRRP, in a multisite sample of hos-
pital discharges.
METHODS
Study Design and Participants
This was a retrospective cohort study of medical in-
patients discharged alive between January 1, 2011 and De-
cember 31, 2011 from 6 hospitals in the United States: San
Francisco General Hospital, University of California, San
Francisco, CA; Hospital of the University of Pennsylvania,
Philadelphia, PA; Harborview Medical Center at the Uni-
versity of Washington, Seattle, WA; Vanderbilt University
Medical Center in Nashville, TN; Northwestern Memorial
Hospital in Chicago, IL; Christiana Hospital and Wilmington
Hospital in Wilmington, DE. Nearly all are large academic
tertiary care facilities. All participate in the International
Cohort of Avoidable REadmissions (ICARE) consortium.9
The non-US hospitals that are a part of ICARE were ex-
cluded from this analysis given the focus on conditions tar-
geted by the HRRP specific to the United States. We
collected data from the electronic health record of individual
hospitals because calculation of the HOSPITAL score re-
quires knowledge of laboratory studies, prior admissions,
and primary treating service; these factors are not found in
national samples of hospital discharges. As the HOSPITAL
score was originally derived and validated in medical in-
patients (surgical patients were excluded) this study was
similarly restricted to patients discharged from an inpatient
medical service.
Patients were excluded if they transferred to another
inpatient health care facility (hospital or psychiatric hospi-
tal), discharged against medical advice, or had a hospital
length of stay of <1 day. The study had Institutional Review
Board approval from each site and the managing site at
Brigham and Women’s Hospital in Boston, Massachusetts.
Identifying Potentially Preventable
Readmissions
All 30-day readmissions to any division of these hos-
pitals were identified first. As the unit of analysis was a
hospital discharge, a discharge could be considered an index
admission and a readmission if several hospital stays oc-
curred within 30 days. Potentially preventable readmissions
from this cohort were identified using the SQLape algorithm
as was performed in studies validating the HOSPITAL
score.8,9 This algorithm uses administrative data to catego-
rize readmissions as “unavoidable” or “potentially pre-
ventable.”8,11,12 The SQLape algorithm was developed from
physician adjudication of >3000 reviewed patient charts,
then validated in >130,000 patients across 49 hospitals, in-
cluding a 12-hospital chart review study for validation.11 It
uses a similar method to CMS for determining “planned”
readmissions, but goes further to identify other unavoidable
and avoidable hospitalizations.13,14 Thus, “potentially pre-
ventable” readmissions determined by SQLape would be
considered unplanned readmissions by CMS, but not all
unplanned readmissions would be considered “potentially
preventable” by SQLape. Further details about the SQLape
algorithm are listed in the Supplemental Appendix (Sup-
plemental Digital Content 1, http://links.lww.com/MLR/
B303).
As a sensitivity analysis, we also evaluated perfor-
mance of the HOSPITAL score on all readmissions (not just
those considered potentially preventable); in this analysis
any patient with a 30-day readmission was compared with
those without a readmission in this time frame. This is
similar to the CMS measure. We also conducted a sensitivity
analysis restricting to patients 65 years of age or above as a
proxy for Medicare beneficiary status as we were unable to
capture payor source as a part of our dataset and Medicare
claims lacked the requisite data to calculate the HOSPITAL
score.
Calculating the HOSPITAL Score
The development of the HOSPITAL score has been
previously described.8 Briefly, it was originally derived and
internally validated at a single academic US hospital in a
sample of discharged medical inpatients.8 Logistic regression
with backward selection was performed to identify the most
significant predictors of potentially preventable readmissions
within 30 days of discharge (Table 1). Score points were
attributed to each of the 7 predictive variables identified
using a regression coefficient–based scoring method. It was
then validated in an international sample of all medical in-
patients discharged from 9 hospitals from 4 countries (the
ICARE consortium, which was created initially for this
purpose), involving >110,000 records.9 This study represents
a subsample of this validation study, restricted to the US
hospitals that participated.
The HOSPITAL score (Table 1) includes 7 variably
weighted predictor variables associated with potentially
preventable 30-day readmissions in derivation and validation
studies.8,9 These variables include assessment of the number
of hospital admissions in the prior 12 months, urgency of
admission (urgent or emergent vs. nonemergent), last avail-
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able laboratory studies (hemoglobin and sodium levels),
discharge from an oncology division, any medical proce-
dures or complex imaging performed during the index hos-
pitalization, and the index hospital length of stay. As only
nonsurgical patients were enrolled, medical procedures in-
cluded those traditionally performed by a medical physician,
such as endoscopy, hemodialysis, transfusion, percutaneous
coronary interventions, or bedside procedures like para-
centesis or thoracentesis. Complex imaging studies included
computed tomographic scans or magnetic resonance imag-
ing. Laboratory studies were the only missing data in this
analysis; of 78,921 patients in the cohort, 6259 had missing
hemoglobin values, 7.9%, and 3076 had missing sodium
values, 3.9%. This means that these laboratory studies were
not measured during the course of the hospitalization in
question; thus, we have assumed that the patient did not have
these risk factors.
The scoring system ranges from 0 to 13 points with
higher scores connoting higher risk of readmission. These
risks were further categorized into 3 groups: low risk (up to 4
points); intermediate risk (5–6 points); and high risk (7 or
more points), roughly corresponding to 5%, 10%, and 20%
risk of potentially preventable 30-day readmissions, re-
spectively.8,9
Measuring HOSPITAL Score Performance
We used a multivariable logistic regression model in-
cluding the HOSPITAL score with a fixed effect for hospitals
to account for differences in outcomes across hospitals. We
used a robust sandwich variance estimator to account for
repeated events by the same patient within hospitals. We
calculated the overall performance, the discriminatory
power, and the calibration of this model for each of the
medical diagnoses targeted by the HRRP: acute myocardial
infarction, chronic obstructive pulmonary disease (COPD),
pneumonia, or heart failure (HF). We used Medicare’s
methodology for identifying these conditions as described in
the 2015 Final Rule.14
We used the Brier score to quantify accuracy, or how
close predictions are to the actual outcome. Scores range
from 0 (best performance) to 0.25 (noninformative). We
calculated the c-statistic to evaluate discrimination; that is,
the ability of the HOSPITAL score to discriminate between
those with a potentially preventable 30-day readmission and
those without a potentially preventable 30-day readmission.
The c-statistic was obtained through a logistic regression
model that included all variables in the HOSPITAL score,
whereas the calibration evaluates how closely the predicted
readmission rate matches the true observed rate within each
of the 3 risk score categories described above. Finally, we
used the Hosmer-Lemeshow goodness-of-fit test to measure
calibration of the model, reporting observed and predicted
rates for each deciles of risk; a PZ0.05 implies a good fit,
with higher numbers signifying better fit.15 Analyses were
performed with SAS Software, version 9.3 (SAS Institute
Inc., Cary, NC).
RESULTS
Of 78,921 discharges during the study period, 9181
(11.6%) were discharged after treatment for one of the
HRRP-targeted conditions [pneumonia (n = 3335, 4.2%), HF
(n = 3189, 4.0%), COPD (n = 1890, 2.4%), acute myocardial
infarction (n = 767, 1.0%)]. The potentially avoidable read-
mission rate across these diagnoses was 13.6% overall
(Fig. 1). Patients treated for HRRP-targeted conditions who
had potentially preventable readmissions were more likely to
have low sodium and hemoglobin levels and to have more
prior admissions in the past year (Table 2).
Across all 4 diagnoses, the HOSPITAL score had very
good accuracy (Brier score = 0.11) good discrimination [c-
statistic = 0.68 (95%CI, 0.66–0.70)], and very good calibra-
tion (Hosmer-Lemeshow goodness-of-fit P= 0.77). For ex-
ample, the expected and observed readmission rates were
very similar within each risk subgroup: low risk (9.1% ex-
pected, 9.6% observed), moderate risk (11.3% expected,
11.0% observed), and high risk (18.0% expected, 18.1%
observed). Within diagnoses, accuracy and discrimination
were similar (Brier score, 0.10–0.12; c-statistic, 0.67–0.71),
although calibration was better for pneumonia and COPD
(P = 0.76 and 0.81, respectively) than for acute MI or HF
(P = 0.16 and 0.17, respectively—Table 3). Results were
similar when evaluating only patients age 65 and above
(Table 4) and when considering all readmissions (not just
those considered potentially preventable—Table 5).
DISCUSSION
In this multicenter retrospective cohort, the HOSPI-
TAL score had very good accuracy, discrimination, and
calibration for 30-day potentially preventable readmissions
after inpatient treatment for 1 of the 4 medical conditions
targeted by the Hospital Readmission Reduction Program
(HRRP). These findings are important for practitioners and
hospitals seeking to reduce preventable readmissions and
improve patient outcomes.
The HOSPITAL score may fill a needed niche as a risk
prediction score that is validated in multiple institutions in
the United States and abroad, and identifies a high-risk
population for potentially avoidable admissions. The HOS-
PITAL score has better performance characteristics than
most prediction models using retrospective data in all-cause
readmissions and within specific disease states, separating
the HOSPITAL score from prior risk prediction models.16 In
TABLE 1. HOSPITAL Score Calculation
Characteristics Value Points
Low Hemoglobin level at discharge (< 12 g/dL) Yes 1
Discharge from an Oncology service Yes 2
Low Sodium level at discharge (< 135mmol/L) Yes 1
Procedure during hospital stay Yes 1
Index admission Type: urgent or emergent Yes 1
No. hospital Admissions in prior year r1 0
2–5 2
Z5 5
Index hospitalization Length of stay Z5 d Yes 2
The HOSPITAL score has 13 total points as scored above.
Bold indicates the letters associated with the HOSPITAL acronym from each
characteristic.
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particular, our results suggest that the HOSPITAL score can
be used both to support comprehensive transitional care in-
terventions which have a track record of success,17,18 or
disease-specific interventions within diagnoses penalized as
a part of the HRRP. Examples of integrating a risk prediction
score into an intervention are preliminary,19 but suggest such
a model tailors the intervention to those most at risk, offering
the most promise of reducing readmissions in a maximally
cost-effective manner.
Although the HOSPITAL score can help predict a
high-risk cohort for readmission and segregates out likely
nonpreventable readmissions, it does not explain why the
patient might be readmitted or how to intervene to reduce
readmission risk. Many of the markers in the score (such as
previous hospital admissions) are clearly not modifiable, and
others (low hemoglobin) are likely associated with sicker
patients rather than representing targets for intervention.
Rather, the score could be used to identify a high-risk cohort,
who then could be formally assessed for risk factors for re-
admission that might be modifiable, and receive a tailored
intervention.4,6 Surveys of hospital administrators indicate
that they use both disease-specific and more general inter-
ventions to reduce readmissions.20–22 A relative weakness of
the HOSPITAL score in this regard is that it requires data
available shortly before discharge (length of stay and labo-
ratory studies) which may ultimately affect which risk group
the patient fits into. However, clinicians may find that the
length of stay and likely ranges for these laboratory studies
can often be predicted within 1–2 days before discharge.
The proportion of HRRP-targeted conditions in our
sample was similar to other national data.23 Despite targeting
a minority of conditions, readmission rates may be improv-
ing nationally both for targeted and nontargeted con-
ditions23–25; Medicare is adding additional conditions each
year.26
Although a full discussion of the relative preventability
of readmissions is beyond the scope of this paper,27–29 we
note recent studies assessing preventability in the eye of
patients and providers document high rates of potentially
preventable readmissions, although these still constitute a
minority of readmissions overall.30–32 In our cohort, the
FIGURE 1. Cohort description and derivation. CMS dx in-
dicates 1 of the 4 medical conditions targeted by the Medicare
Hospital Readmission Reductions Program; COPD, chronic
obstructive pulmonary disease; PAR, potentially avoidable re-
admission. The number of patients (and proportion of the
overall total) are listed.





No Potentially Preventable Readmission
(N=7929) (86.4%) P
Age [mean (SD)] (y) 65.4 (15.9) 65.9 (17.0) 0.21
Male (%) 51.4 47.5 0.01
Hospital diagnosis (%) < 0.01
Pneumonia 30.2 37.3
Heart failure 39.2 34.0
COPD 22.8 20.2
Acute MI 7.8 8.5
Low Hemoglobin level 66.5 58.1 < 0.01
Discharge from Oncology service 3.8 2.2 < 0.01
Low Sodium level 82.2 86.2 < 0.01
Procedure during hospital stay 70.2 67.5 0.06
Urgent or emergent Index admission Type 87.9 85.9 0.06
No. Admissions in past year < 0.01
r1 40.3 66.0
2–5 41.2 29.7
> 5 18.5 4.4
Index hospital LOS Z5 d 49.8 42.5 < 0.01
HOSPITAL score categories < 0.01
Low risk (r4 points) 515 (41.1) 4922 (62.1)
Intermediate risk (5–6 points) 347 (27.7) 2027 (25.6)
High risk (Z7 points) 390 (31.2) 980 (12.4)
Bold signifies letters comprising the HOSPITAL score and statistically significant P-values.
COPD indicates chronic obstructive pulmonary disease; HRRP, Hospital Readmissions Reduction Program; LOS, length of stay; MI, myocardial infarction.
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preventable readmission rate was lower than in these studies.
This may reflect the difference between using administrative
data versus interviews or comprehensive chart review of
readmissions to determine preventability. It should be noted
that there is currently no consensus on how to identify with
certainty which readmissions are truly preventable, no matter
how laborious the process. Not all potentially preventable
readmissions identified through administrative data and/or
electronic health records (such as those identified by
SQLape) may be preventable. For example, in SQLape’s
largest validation study, the true positive rate for identifying
potentially preventable readmissions was 78% based on
medical chart review, with most errors related to coding
rather than errors in the algorithm.11 However, we feel the
advantages of SQLape—including its transparent design,
large multisite derivation, and validation samples with chart
review substudies for validation—outweigh potential mis-
classification bias, particularly compared with the CMS all-
cause readmission measure (which does not attempt to
identify any readmissions as potentially preventable) or other
tools to assess preventable readmissions using administrative
data, which have not been externally validated.33 Many
hospitals and providers will seek to identify an enriched
cohort of potentially avoidable readmissions using admin-
istrative data, a niche the HOSPITAL score may help to fill.
This study should be considered in the context of the
data analyzed. As the HOSPITAL score was derived and
validated in medical patients, it has not been studied in
surgical populations or for surgical diagnoses (eg, joint re-
placement) targeted by the HRRP. Although very few pa-
tients were coded as being discharged from an oncology
service, none of the HRRP-targeted measures is primarily
associated with an oncologic diagnosis, raising concern
about whether this coding was accurate. Anecdotally, on-
cology services at some hospitals in our sample also admit
their own patients for acute medical concerns, not just for
scheduled chemotherapy, potentially explaining this finding.
The HOSPITAL score does not include several im-
portant predictors of hospital readmission, such as functional
status,32,33 socioeconomic status,34 or hospital character-
istics.24 However, these characteristics are infrequently
captured in administrative data, and the HOSPITAL score
was purposefully limited to 7 variables to increase clinical
applicability and ease of use. Diagnoses treated are subject to
coding error, and we were unable to conduct chart review to
confirm coding accuracy or validate readmissions flagged as
potentially avoidable using the SQLape algorithm. Although
the original score was validated in 9 centers across 4 coun-
tries, this analysis was limited to predominantly large aca-
demic medical centers, and the predictive characteristics of
the HOSPITAL score may be different in other settings for
HRRP-targeted conditions.
We did not compare the performance of the HOSPI-
TAL score with CMS’s risk-adjustment model for hospital
readmissions as the intent of the 2 models is different. The
HOSPITAL score was derived and validated to predict 30-
day potentially avoidable readmissions, whereas CMS’s risk-
adjustment measure was developed to enable comparison of
readmission rates across hospitals through adjustment for
patient readmission risk factors that may be unequally dis-
tributed across hospitals. We also did not attempt to derive a
new risk prediction score for HRRP-targeted conditions, but
rather to analyze the performance of the original HOSPITAL
score in these specific populations. Thus, while some pre-
dictors that were valid in the original derivation study did
not meet statistical significance and other predictors could
have better performance in these select populations, the
overall value of the HOSPITAL score lies in its prediction of
potentially preventable readmissions across medical in-
patients in a variety of contexts, as well as its performance
TABLE 3. HOSPITAL Score Performance in Potentially Preventable 30-Day Readmissions
Characteristics Discharges (N) 30-Day Readmission Rate (%) Brier Score c-Statistic (95% CI) Hosmer-Lemeshow (P)
All CMS diagnoses 9181 13.6 0.11 0.68 (0.66–0.70) 0.77
Pneumonia 3335 11.3 0.10 0.68 (0.65–0.71) 0.76
Heart failure 3189 15.4 0.12 0.68 (0.65–0.70) 0.17
Acute MI 767 12.7 0.11 0.67 (0.61–0.72) 0.16
COPD 1890 15.1 0.12 0.71 (0.67–0.74) 0.81
CI indicates confidence interval; CMS, Center of Medicare and Medicaid Services; COPD, chronic obstructive pulmonary disease; MI, myocardial infarction.
TABLE 4. HOSPITAL Score Performance in Potentially Preventable 30-Day Readmissions Restricted to Patients Age 65 Years or
Above
Characteristics Discharges (N) 30-Day Readmission Rate (%) Brier Score c-Statistic (95% CI) Hosmer-Lemeshow (P)
All CMS diagnoses 5087 13.2 0.11 0.66 (0.63–0.68) 0.27
Pneumonia 1717 11.8 0.10 0.64 (0.60–0.69) 0.27
Heart failure 1918 14.1 0.12 0.68 (0.64–0.71) 0.37
Acute MI 421 12.4 0.12 0.68 (0.61–0.76) 0.56
COPD 1031 14.1 0.10 0.67 (0.62–0.72) 0.71
CI indicates confidence interval; CMS, Center of Medicare and Medicaid Services; COPD, chronic obstructive pulmonary disease; MI, myocardial infarction.
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for HRRP-targeted conditions. A single score that performs
well in all contexts has more utility than multiple in-
dividualized scores specialized to specific contexts.
The HOSPITAL score is a valid risk prediction model
for 30-day potentially preventable readmissions across all
readmissions and within important disease-specific catego-
ries. As such, it may serve as a key part of future cost-
effective interventions to reduce preventable readmissions.
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TABLE 5. HOSPITAL Score Performance in All 30-Day Readmissions
Characteristics Discharges (N) 30-Day Readmission Rate (%) Brier Score c-Statistic (95% CI) Hosmer-Lemeshow (P)
All CMS diagnoses 9181 16.3 0.13 0.68 (0.66–0.69) 0.41
Pneumonia 3335 13.8 0.13 0.68 (0.65–0.70) 0.49
Heart failure 3189 18.2 0.13 0.67 (0.65–0.70) 0.10
Acute MI 767 17.4 0.13 0.66 (0.61–0.71) 0.49
COPD 1890 16.6 0.13 0.70 (0.67–0.73) 0.84
CI indicates confidence interval; CMS, Center of Medicare and Medicaid Services; COPD, chronic obstructive pulmonary disease; MI, myocardial infarction.
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